Concepedia

Andrew Belch

AB

Statistics

Publications

37

Citations

7K

H-Index

25

Active since

1980

Affiliations

University of Calgary(Current)

National and Kapodistrian University of Athens

Dana-Farber Cancer Institute

Mayo Clinic in Arizona

Janssen (United States)

Andrew Belch is an author at University of Calgary specializing in medicine, hematologic malignancy therapy, and multiple myeloma therapy.

ORCID

Publications per year

1980–2020

37

Publications

37

International uniform response criteria for multiple myeloma

Brian G.M. Durie, J-L Harousseau, Jesús F. San Miguel et al. · Leukemia · 2006 · 2.6K citations

, , +12

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

Antonio Palumbo, Sara Bringhen, María‐Victoria Mateos et al. · Blood · 2015 · 762 citations · Full text

, , +16

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations

, , +15

Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma

Saad Z. Usmani, Brendan M. Weiss, Torben Plesner et al. · Blood · 2016 · 404 citations · Full text

, , +14

Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study

Paul G. Richardson, David S. Siegel, Ravi Vij et al. · Blood · 2014 · 384 citations · Full text

, , +13

1–5 of 37